MYX 3.29% $4.40 mayne pharma group limited

Mithra’s Donesta phase 3 trial results

  1. 351 Posts.
    lightbulb Created with Sketch. 201
    Mithra released their stage 3 efficacy trials a couple of days ago regarding menopausal treatments.
    The results were outstanding.
    I can’t see how rulers are not being run over these companies given MYX cash position and Mithra’s
    focus on womens health.

    It’s just a matter of time IMO before we see something between these two entities.
 
watchlist Created with Sketch. Add MYX (ASX) to my watchlist
(20min delay)
Last
$4.40
Change
0.140(3.29%)
Mkt cap ! $374.3M
Open High Low Value Volume
$4.25 $4.43 $4.25 $618.9K 141.5K

Buyers (Bids)

No. Vol. Price($)
10 2957 $4.40
 

Sellers (Offers)

Price($) Vol. No.
$4.41 968 1
View Market Depth
Last trade - 16.10pm 12/07/2024 (20 minute delay) ?
MYX (ASX) Chart
arrow-down-2 Created with Sketch. arrow-down-2 Created with Sketch.